A new alternative in the treatment of hand eczema: Topical pimecrolimus;El ekzemasi tedavisinde yeni bir seçenek: Topikal pimekrolimus

Turkderm Deri Hastaliklari ve Frengi Arsivi

Volumn 41, Issue 4, 2007, Pages 125-128

  Başkan, Emel Bülbül ^a   Kaçar, Seval Doǧruk ^a   Turan, Ayşegül ^a   Tunali, Şükran ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Hand eczema; Pimecrolimus

Indexed keywords

PIMECROLIMUS;

ABSENCE OF SIDE EFFECTS; ADULT; AGRICULTURAL WORKER; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTACT DERMATITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DESQUAMATION; DISEASE DURATION; DRUG EFFICACY; ECZEMA; EDEMA; ERYTHEMA; FEMALE; FOLLOW UP; HEALTH CARE PERSONNEL; HUMAN; LICHENOID ERUPTION; MALE; POLICE; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SKIN ALLERGY; SKIN FISSURE; SYMPTOMATOLOGY; TACHYPHYLAXIS; TEACHER; TREATMENT DURATION;

EID: 51549101990     PISSN: 1019214X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Rycroft RJG: Occupational dermatoses. In: Champion RH, Burton JL, Burns DA, Ebling FJG (eds). Textbook of Dermatology. Altinci Baski. Blackwell-Science:London; 1998:861-882.
2. Elston DM, Ahmet DDF, Watsky KL, Schwarzenberger K: Hand dermatitis. J Am Acad Dermatol 2002; 47:291-299.
3. Meding B: Epidemiology of hand eczema in an industrial city. Acta Derm Venereol 1990;153:1-43.
4. Coenraads PJ, Nater JP: Sickness and absence from work due to skin diseases in the construction industry. Review of literature. Derm Beruf Umwelt 1984;32:17-21.
5. Adiesh A, Meyer JD, Cherry NM: Prognosis and work absence due to occupational contact dermatitis. Contact Dermatitis 2002;46:273-279.
6. Halkier-Sorensen L: Occupational skin diseases. Contact Dermatitis 1996;35:1-120.
7. Cvetkovski RS, Rothman KJ, Olsen J, Mathiesen B et al: Relation between diagnoses on severity, sick leave and loss of job among patients with occupational hand eczema. Br J Dermatol 2005;152:93-98.
8. Marks R: Adverse side effects from the use of topical corticosteroids. In: Maibach HI, Surger C, eds. Topical Corticosteroids. Basel. Karger 1992;170-83.
9. Queille Roussel C, Graeber M Thurston M et al: SDZ ASM 981 is the first non-steroid that suppresses established nickel-contact dermatitis elicited by allergen challenge. Contact Dermatitis 2000;42:349-350.
10. Thaci D, Steinmeyer K, Ebelin ME, Scott G, Kaufmann R: Occlusive treatment of chronic hand dermatitis with pimecrolimus cream 1% results in low systemic exposure, is well tolerated,safe and effective.An open study. Dermatology 2003;207:37-42.
11. Belsito DV, Fowler JF Jr, Marks JG Jr, et al: Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitis. Cutis 2004;73:31-38.
12. Gupta AK, Chow M: Pimecrolimus. A review. J Eur Acad Dermatol Venereol 2003:17: 493-503.
13. Grassberger M, Baumruker T, Enz A et al: A novel anti-inflammatory drug SDZ ASM 981 for the treatment of skin diseases: in vitro pharmacology. Br J Dermatol 1999;141:263-273.
14. Özkaya-Bayazit E, Özarmaǧan G: Mesleǧe baǧli el ekzemalarinda medikal ve hukuksal yaklaşim. Turkderm 1998;8-28.
15. Schurmeyer-Horst F, Luger TA, Bohm M: Long-term efficacy of occlusive therapy with topical pimecrolimus in severe dyshidrosiform hand and foot eczema. Dermatology 2007;214:99-100.